BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 24878186)

  • 1. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
    Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
    J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
    Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
    Lin YL; Wu MT; Yang FY
    J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
    Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
    Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
    Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
    J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
    Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT
    PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
    Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK
    Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.
    Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N
    J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment.
    Wei HJ; Upadhyayula PS; Pouliopoulos AN; Englander ZK; Zhang X; Jan CI; Guo J; Mela A; Zhang Z; Wang TJC; Bruce JN; Canoll PD; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):539-550. PubMed ID: 33346092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas.
    Arrieta VA; Gould A; Kim KS; Habashy KJ; Dmello C; Vázquez-Cervantes GI; Palacín-Aliana I; McManus G; Amidei C; Gomez C; Dhiantravan S; Chen L; Zhang DY; Saganty R; Cholak ME; Pandey S; McCord M; McCortney K; Castro B; Ward R; Muzzio M; Bouchoux G; Desseaux C; Canney M; Carpentier A; Zhang B; Miska JM; Lesniak MS; Horbinski CM; Lukas RV; Stupp R; Lee-Chang C; Sonabend AM
    Nat Commun; 2024 Jun; 15(1):4698. PubMed ID: 38844770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery.
    Fan CH; Ting CY; Chang YC; Wei KC; Liu HL; Yeh CK
    Acta Biomater; 2015 Mar; 15():89-101. PubMed ID: 25575854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
    Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
    J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.